Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

A polymer coating applied to Salmonella prevents the binding of Salmonella-specific antibodies.

Lee CH, Lin YH, Hsieh JL, Chen MC, Kuo WL.

Int J Cancer. 2013 Feb 1;132(3):717-25. doi: 10.1002/ijc.27700. Epub 2012 Jul 14.

2.

Humoral immune responses inhibit the antitumor activities mediated by Salmonella enterica serovar choleraesuis.

Lee CH, Wu CL, Chen SH, Shiau AL.

J Immunother. 2009 May;32(4):376-88. doi: 10.1097/CJI.0b013e31819d4ebc.

PMID:
19342967
3.

T cell augments the antitumor activity of tumor-targeting Salmonella.

Lee CH, Hsieh JL, Wu CL, Hsu PY, Shiau AL.

Appl Microbiol Biotechnol. 2011 May;90(4):1381-8. doi: 10.1007/s00253-011-3180-z. Epub 2011 Mar 1.

PMID:
21360146
6.

[Therapeutic intervention alternatives in cancer, using attenuated live bacterial vectors: Salmonella enterica as a carrier of heterologous molecules].

Hernández-Luna MA, Luria-Pérez R, Huerta-Yépez S.

Rev Invest Clin. 2013 Jan-Feb;65(1):65-73. Review. Spanish.

PMID:
23745445
7.

Host and bacterial factors affecting induction of immune responses to flagellin expressed by attenuated Salmonella vaccine strains.

Sbrogio-Almeida ME, Mosca T, Massis LM, Abrahamsohn IA, Ferreira LC.

Infect Immun. 2004 May;72(5):2546-55.

8.

Immunogenicity of Salmonella enterica serovar Enteritidis virulence protein, InvH, and cross-reactivity of its antisera with Salmonella strains.

Dehghani B, Rasooli I, Gargari SL, Nadooshan MR, Owlia P, Nazarian S.

Microbiol Res. 2013 Feb 22;168(2):84-90. doi: 10.1016/j.micres.2012.09.002. Epub 2012 Nov 6.

9.
10.

Toll-like receptor 4 mediates an antitumor host response induced by Salmonella choleraesuis.

Lee CH, Wu CL, Shiau AL.

Clin Cancer Res. 2008 Mar 15;14(6):1905-12. doi: 10.1158/1078-0432.CCR-07-2050.

11.
12.

Ribonucleic acid in the immune response.

Mitsuhashi S, Saito K, Kurashige S, Yamaguchi N.

Mol Cell Biochem. 1978 Aug 16;20(3):131-47. Review.

PMID:
81465
13.

Mucosal innate immune response to intragastric infection by Salmonella enterica serovar Choleraesuis.

Hyland KA, Kohrt L, Vulchanova L, Murtaugh MP.

Mol Immunol. 2006 Apr;43(11):1890-9. Epub 2005 Dec 1.

PMID:
16325910
14.

The molecular adjuvant mC3d enhances the immunogenicity of FimA from type I fimbriae of Salmonella enterica serovar Enteritidis.

Musa HH, Zhang WJ, Lv J, Duan XL, Yang Y, Zhu CH, Li HF, Chen KW, Meng X, Zhu GQ.

J Microbiol Immunol Infect. 2014 Feb;47(1):57-62. doi: 10.1016/j.jmii.2012.11.004. Epub 2013 Jan 24.

15.

Tumor-targeting amino acid auxotrophic Salmonella typhimurium.

Hoffman RM.

Amino Acids. 2009 Sep;37(3):509-21. doi: 10.1007/s00726-009-0261-8. Epub 2009 Mar 17. Review.

PMID:
19291366
16.

Caveolin-1-deficient mice show defects in innate immunity and inflammatory immune response during Salmonella enterica serovar Typhimurium infection.

Medina FA, de Almeida CJ, Dew E, Li J, Bonuccelli G, Williams TM, Cohen AW, Pestell RG, Frank PG, Tanowitz HB, Lisanti MP.

Infect Immun. 2006 Dec;74(12):6665-74. Epub 2006 Sep 18.

18.
19.

Supplemental Content

Support Center